1-6 of 6
Jens Pedersen-Bjergaard
Close
Sort by
Journal Articles

IDH1 and IDH2 Mutations in Therapy-Related Acute Myeloid Leukemia Are Associated with a Normal Karyotype or Der(1;7)(q10;p10) Combined with RUNX1 Mutations,

Maj K. Westman, Morten T. Andersen, Jens Pedersen-Bjergaard, MD, PhD, Mette K. Andersen, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3514.
https://doi.org/10.1182/blood.V118.21.3514.3514
Published: 2011
Journal Articles

Genetic Pathways in t-MDS and t-AML, a Revised Model.

Jens Pedersen-Bjergaard, MD, Ph.D, Debes H. Christiansen, MS, Mette K. Andersen, MD
Journal: Blood
Blood (2004) 104 (11): 2993.
https://doi.org/10.1182/blood.V104.11.2993.2993
Published: 2004
Journal Articles

Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation

Debes H. Christiansen, Mette K. Andersen, Jens Pedersen-Bjergaard
Journal: Blood
Blood (2004) 104 (5): 1474–1481.
https://doi.org/10.1182/blood-2004-02-0754
Published: 2004
Journal Articles

Therapy-related MDS and AML in acute promyelocytic leukemia

Mette Klarskov Andersen, Jens Pedersen-Bjergaard
Journal: Blood
Blood (2002) 100 (5): 1928–1930.
https://doi.org/10.1182/blood-2002-03-0962
Published: 2002
Journal Articles

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

Jens Pedersen-Bjergaard, Mette K. Andersen, Debes H. Christiansen, Claus Nerlov
Journal: Blood
Blood (2002) 99 (6): 1909–1912.
https://doi.org/10.1182/blood.V99.6.1909
Published: 2002
Journal Articles

Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation

Jens Pedersen-Bjergaard, Mette Klarskov Andersen, Debes H. Christiansen
Journal: Blood
Blood (2000) 95 (11): 3273–3279.
https://doi.org/10.1182/blood.V95.11.3273
Published: 2000